Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal E-Jurnal Medika Udayana Cermin Dunia Kedokteran Cermin Dunia Kedokteran
Widyawati Suhendro
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
PSYCHOTHERAPY SUPPORT ON SCIZOPHRENIA Widyawati Suhendro
E-Jurnal Medika Udayana vol 2 no 12 (2013):e-jurnal medika udayana
Publisher : Universitas Udayana

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (148.589 KB)

Abstract

Schizophrenia is a disease that causes varying descriptions. The symptoms of schizophrenia are divided into two groups, the primary and secondary symptoms. Treatment should be done as soon as possible, because a state of psychotic periods raises the possibility to suffer mental decline. The treatment is carried out must be comprehensive, multimodal, empirically and can be applied to the patient. One therapy that is given is psychotherapy. Psychotherapy is usually combined with pharmacological actions in order to increase the level of maximum healing.
Tata Laksana Lambert Eaton Myasthenic Syndrome Marcellinus Michael Leonard Mardiono; Widyawati Suhendro
Cermin Dunia Kedokteran Vol 50 No 11 (2023): Pediatri
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v50i11.676

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is a neuromuscular junction disorder resulting from a paraneoplastic or autoimmune reaction. More than half LEMS cases are associated with small cell lung carcinoma (SCLC). The main clinical manifestation is muscle weakness. The pathophysiology is due to the generation of the autoantibodies against voltage-gated calcium channels (VGCCs) on presynaptic nerve terminals leading to a decrease in neurotransmitter acethylcholine (ACh). Various treatments such as tumor treatments, immunomodulatory, and symptomatic treatment have been studied, but further research is needed.
Tata Laksana Lambert Eaton Myasthenic Syndrome Marcellinus Michael Leonard Mardiono; Widyawati Suhendro
Cermin Dunia Kedokteran Vol 50 No 11 (2023): Pediatri
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v50i11.676

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is a neuromuscular junction disorder resulting from a paraneoplastic or autoimmune reaction. More than half LEMS cases are associated with small cell lung carcinoma (SCLC). The main clinical manifestation is muscle weakness. The pathophysiology is due to the generation of the autoantibodies against voltage-gated calcium channels (VGCCs) on presynaptic nerve terminals leading to a decrease in neurotransmitter acethylcholine (ACh). Various treatments such as tumor treatments, immunomodulatory, and symptomatic treatment have been studied, but further research is needed.
Co-Authors Marcellinus Michael Leonard Mardiono